Eczema herpeticum in Adult
Eczema herpeticum is more commonly seen in patients with atopic dermatitis but may also be seen in cases of Darier disease, autoimmune bullous dermatoses, burns, mycosis fungoides, pityriasis rubra pilaris, and other forms of dermatitis such as irritant contact and seborrheic dermatitis. It mostly affects children but can occur in any age group.
Risk factors that have been proposed for the development of eczema herpeticum include mutations in filaggrin and deficiency of cathelicidins, skin antimicrobial peptides, in the skin.
Patients can develop numerous vesicles that may appear in successive crops for several days. Associated systemic symptoms can include high fevers, lymphadenopathy, and malaise. The primary infection is usually more severe than recurrent episodes.
Complications of eczema herpeticum include secondary bacterial infection and multiorgan involvement, including keratoconjunctivitis, meningitis, and encephalitis. Commonly implicated pathogens in bacterial superinfection include Staphylococcus aureus and Streptococcus pyogenes. Systemic viremia can result in serious morbidity and mortality, especially in infants.
The disease is typically self-limited, lasting 2-4 weeks, but can be shortened by antiviral therapy. In healthy adult patients, mild cases can be self-limiting. In children and young infants, this condition is a medical emergency, and early treatment with antiviral therapy is required.
B00.0 – Eczema herpeticum
186535001 – Eczema herpeticum
Differential Diagnosis & Pitfalls
Drug Reaction Data